✦ LIBER ✦

Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer

✍ Scribed by Perran F Yumuk; Nazim S Turhal; Mahmut Gumus; Nilgun F Hatabay; Orhan Turken; Alper Ozkan; Taflan Salepci; Mehmet Aliustaoglu; Rengin Ahiskali

Book ID: 115010619
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 275 KB
Volume: 5
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-5-10

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on “Induction and Concurrent

Commentary on “Induction and Concurrent Paclitaxel/Carboplatin Every 3 Weeks with Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: An Interim Report”

✍ Julian G. Rosenman 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 49 KB

Induction chemotherapy followed by weekl

Induction chemotherapy followed by weekly paclitaxel and carboplatin with concurrent radiotherapy in inoperable stage III non-small cell lung cancers: results of a phase II trial

✍ Hend Ahmed El-Hadaad,Hanan Ahmed Wahba… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 255 KB

Expression of ERCC1 and class IIIβ tubul

Expression of ERCC1 and class IIIβ tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer

✍ Satoshi Ikeda; Kazuhiko Takabe; Keiko Suzuki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Very low acute toxicity of three fractio

Very low acute toxicity of three fractions per day accelerated radiotherapy given after induction chemotherapy and surgery in stage III non- small cell lung cancer

✍ de Pas, Tommaso; Catalano, Giampiero; Pastorino, Ugo; de Braud, Filippo; Jerecze 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Dose-finding study of fixed dose gemcita

Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer

✍ Baka, S.; Manegold, C.; Buchholz, E.; Schott-von-Römer, K.; Lorigan, P.; Nagel, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 109 KB

P-209 Comparison of three cisplatin (P)

P-209 Comparison of three cisplatin (P) doublets — Gemcitabine/P (GP), paclitaxel/P (TP), etoposide/P (EP) in advanced (stage IIIB and IV) non-small cell lung cancer (NSCLC)

✍ Ciuleanu, Tudor E.; Marian, Marisca; Todor, Nicolae; Cebotaru, Cristina; Iancu, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 191 KB